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Abstract 
It has been challenging to identify clinical cognitive markers that can differentiate patients with Alzheimer’s 
disease (AD) from those with behavioral variant frontotemporal dementia (bvFTD). The Short-term 
Memory Binding (STMB) test assesses the ability to integrate colors and shapes into unified representations 
and to hold them temporarily during online performance. The objective of this study is to investigate 
whether free recall deficits during short-term memory binding (STMB) test can differentiate patients with 
AD from those with bvFTD and controls. Participants were 32 cognitively intact adults, 35 individuals with 
AD and 18 with bvFTD. All patients were in the mild dementia stage. Receiver-operating characteristics 
(ROC) analyses were used to examine the diagnostic accuracy of the STMB. The results showed that AD 
patients performed significantly worse than controls and bvFTD patients in the STMB test, while the latter 
groups showed equivalent performance. The bound condition of the STMB test showed an AUC of 0.853, 
with 84.4% of sensitivity and 80% of specificity to discriminate AD from controls and an AUC of 0.794, 
with 72.2% of sensitivity and 80% of specificity to differentiate AD from bvFTD. Binding deficits seem 
specific to AD. The free recall version of the STMB test can be used for clinical purposes and may aid in 
the differential diagnosis of AD. Findings support the view that the STMB may be a suitable cognitive 
marker for AD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
It has been challenging to identify clinical cognitive markers that can differentiate patients with AD from 
those with behavioral variant frontotemporal dementia (bvFTD). There is considerable overlap in cognitive 
scores between these two conditions [1] and recent studies failed to find the expected executive function 
(bvFTD) and episodic memory (AD) asymmetry between these two dementia sub-types [2,3], especially in 
the mild dementia stages [4]. Therefore, a cognitive test that could contribute to the differential diagnosis 
between AD and bvFTD would be valuable. 
 
The Short-term Memory Binding (STMB) test assesses the ability to integrate colors and shapes into unified 
representations and hold them temporarily during online performance [5]. Previous studies have shown that 
STMB is not affected by normal ageing. Relative to young adults, healthy older adults have shown no 
additional cost when remembering bindings as compared to remembering single features [5–8]. Moreover, 
STMB seems to be insensitive to the educational level of the individual [9]. Besides, the STMB is not 
affected by repeated testing or practice [10]. Finally, STMB has been shown to capture a specific deficit in 
AD patients. The test differentiated pre-clinical familial AD from controls [11], AD dementia from chronic 
depression in the elderly [12], and AD from non-AD dementias [13]. This evidence has led to the suggestion 
that the STMB may be a suitable cognitive marker for AD or pre-clinical AD [14].  
 
There are different STMB paradigms and in clinical settings two versions have been used. One uses the 
change detection paradigm [6], in which participants are asked to recognize changes in colors, shapes or 
their combination across two consecutives screens. The other is a free recall version of the STMB test 
[13,15] in which participants are required to verbally recall objects and colors individually or in 
combinations. The present study relied on the free recall version of the STMB test.  
 
Parra and colleagues[15] demonstrated that, when compared with controls, AD patients showed a specific 
deficit in holding integrated features in verbal short-term memory. Della Sala and colleagues[13] reported 
that only AD patients showed significant deficits in recalling object-colors bindings when compared to 
patients that suffered from other types of dementias. In these two previous studies, controls and patients 
performed tasks with different set sizes. This procedure was aimed at titrating the difficulty of the task to 
keep performance level on baseline conditions (i.e., single features) similar across groups. This procedure, 
however, may not be suitable to be used in clinical settings. Therefore, it remains to be investigated whether 
the free recall STMB test differentiates AD from controls and other dementias, when the same difficulty 
level is used for all groups.  
The present study investigated whether free recall deficits during STMB differentiate patients with AD 
from patients with the bvFTD. Based on a previous study [13], we predicted worse scores among AD 
patients and that the free recall STMB would show high accuracy to differentiate AD from controls and 
bvFTD.  
 
Methods 
 
Participants 
Patients were recruited from Neurology outpatient units from the University of São Paulo (USP) and the 
Federal University of Minas Gerais (UFMG). We recruited 42 patients who met criteria for dementia due 
to probable AD based on the NIA-AA  (National Institute on Aging/ Alzheimer’s Association) [16]. Of 
these, 7 were excluded: 3 presented moderate dementia (CDR = 2.0), 1 had visual deficits, 1 had object 
naming problems, 1 was unable to complete the free recall test, and 1 received a diagnosis of Parkinson’s 
disease. For the bvFTD group, we recruited 30 patients who met the international diagnostic criteria for this 
type of dementia [17]. Of these, 11 were excluded: 8 presented moderate dementia (CDR = 2.0), 2 due to 
object naming problems, and 1 patient was unable to complete the free recall test. For the control group, 
we recruited 39 older adults from senior centers and University of Third Age programs (10 from USP 
Ribeirão Preto; 22 from USP São Paulo; and 7 from the Paulista Institute of Geriatrics and Gerontology). 
Of these, 7 were excluded: 5 due to low performance on cognitive tests, 1 participant was not fluent in 
Portuguese and 1 was using psychoactive medication with no stable doses. The final sample consisted of 
35 AD patients, 18 patients with bvFTD, and 32 cognitively healthy older adults (controls). Control 
participants and caregivers of patients with dementia signed the informed consent form which was approved 
by the Ethics Committee from USP (protocol number 16627413.0.0000.0068) and UFMG (protocol 
number CAA 17850513.2.0000.5149). 
 
 
 
Instruments and procedures 
 
All patients were assessed by a neurologist and a neuropsychologist. In neurological care, patients 
underwent a clinical evaluation and screening tests for dementia (MMSE) [18,19] and laboratory and 
neuroimaging exams. Patients completed a neuropsychological battery to assist in the dementia diagnosis. 
The diagnosis was made by neurologists involved in the project. After the diagnosis, patients were referred 
to perform the assessment with the STMB test. Controls completed the neuropsychological battery to 
ascertain normal cognitive status, and, in the same session, they were assessed with the STMB test. 
 
Short-term Memory Binding 
 
Of the free recall paradigm previously used to assess memory binding [5,13] we selected two conditions, 
the unbound and bound features conditions. The rationale behind this selection was that the unbound 
condition represents a better baseline against which the binding cost could be assessed, than conditions 
assessing STMB for single features (i.e., Color or Object Only). This is because the only difference between 
the unbound and bound condition is the need to remember the features together in the latter, that is, the 
binding. At the beginning of the task, participants were presented with two separate arrays - one consisting 
of 20 colors and the other consisting of 20 objects. These arrays consisted of the 11 colors and 11 objects 
used in the experiment and other 9 colors and 9 objects intermixed within the arrays as distractors. 
Participants were requested to name colors and objects to ensure that they had no problems naming the 
items used in the experiment (see section Participants above for the outcomes of this screening test). 
 
Unbound Features: in this condition, the study array consisted of three colors and three objects presented 
as separate features. Half of the items were colored squares and the other half were line drawings of 
common objects. The study array was presented for 9 seconds (1.5 sec per feature). Participants were given 
the following instructions: ‘Now we will test your memory for colors and objects. You will see three colors 
and three objects on the screen. You should try to remember as many colors and objects as you can. After 
these colors and objects disappear, you will have to say aloud all the colors and objects that you have just 
seen’. The experimenter recorded responses using a scoring sheet.  
 
Bound Features: in this condition, the study array consisted of three objects filled with a different color 
each (i.e., colored objects), and was also presented for 9 sec. These colored objects were constructed by 
randomly combining objects with colors from the two sets in a way that avoided prototypical color-object 
associations (e.g., red apple). During this condition participants were asked to try to remember ‘as many 
colored objects as possible, that is, remember each object together with the color in which it was presented’. 
The participants should memorize the combination of colors and objects, for instance: “red-bed”, or “green-
shoe”. A correct response was considered only when the two features (color and object) were recalled 
together.  
 
Each condition (bound and unbound) consisted of 6 trials with 6 features each (3 colors and 3 objects). The 
bound and unbound conditions were counterbalanced. Figure 1 presents an illustration of this task. 
 
 
 
Statistical Analyses 
 
To assess normality in the distribution of the data, the Shapiro-Wilk test was used. Only age followed a 
normal distribution in all groups. Thus, descriptive analyses comparing the clinical groups were carried out 
using the ANOVA test to compare age and the Kruskal-Wallis test was used for the other variables. To 
evaluate the effect of Group, Condition and their interaction, a 3 x 2 mixed model with a between-subject 
factor diagnostic Group (controls, AD and bvFTD) and a within-subject factor Condition (unbound versus 
bound) was used, and to this aim, we relied on the Adjusted Rank Transform test, described by [20], for 
nonparametric data. The effect size, as informed by partial eta-squared (ƞ2), and power by Beta (β), were 
calculated in these mixed models as well. In addition, the binding cost was calculated as the percentage of 
loss in performance observed in the bound condition compared to the unbound condition (Binding cost = 
100 – 100*(bound/unbound)). Receiver-operating characteristics (ROC) analyses were used to examine the 
diagnostic accuracy of the bound STMB and binding cost measures to differentiate between the clinical 
groups. The area under the curve (AUC), specificity and sensitivity values were calculated. Bivariate 
correlations were calculated for STMB (bound condition) with Age, Education and MMSE variables. 
Significance level was set at 0.05. 
 
Results 
 
Sample characteristics and cognitive profiles are presented in Table 1.  Comparisons showed that the three 
groups were equivalent in age and years of formal education. AD and bvFTD patients were in similar stages 
of dementia as informed by CDR. AD patients had worse cognitive performance when compared with 
controls (MMSE, unbound STMB, bound STMB and binding cost). Patients with bvFTD differed from 
controls in the unbound STMB. AD patients differed from bvFTD in the bound STMB and binding cost.  
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Main demographics, functional measure and cognitive tests results statistics 
from the studied groups.  
 
Note. AD = Alzheimer’s disease; bvFTD = behavioral variant Frontotemporal Dementia; SD = standard 
deviation; CDR = Clinical Dementia Rating scale; MMSE=Mini Mental State Examination; STMB – 
unbound = Short-term memory binding for unbound features; STMB – bound = Short-term memory 
binding for bound features; Binding Cost = percentage of the performance drop between the unbound to 
the bound conditions of the free recall STMB; * ANOVA tests; p-values refer to the Kruskal-Wallis test; a 
= differ from controls (p<0.05); b = differ from bvFTD (p<0.05); c = differ from AD (p<0.05). 
 
The results of the adjusted rank transform test showed no significant main effect of test Condition 
[F(1,82)=0.403, p = 0.527, ƞ2 = 0.005, β = 0.096] but there was a significant main effect of diagnostic 
Group [F(1,82)=27.867, p < 0.001, ƞ2 = 0.405, β = 1.000].  In addition, there was a significant interaction 
between Condition and Group [F(1,82)=3.366, p = 0.039, ƞ2 = 0.076, β = 0.620]. When the three groups 
were compared (Figure 2), there was a significant difference between controls and both dementia groups in 
the unbound condition. In the bound condition, however, there was a significant difference between controls 
and AD, bvFTD and AD, but no significant difference between controls and bvFTD patients. 
 
 
 
 
 
 
  Controls 
(n = 32) 
Mean (SD) 
bvFTD 
(n = 18) 
Mean (SD) 
AD 
(n = 35) 
Mean (SD) 
p value 
Age* (years) 67.84 (6.82) 69.09 (8.14) 71.40 (7.96) 0.158 
Education (years) 12.25 (3.69) 11.17 (5.65) 10.09 (5.41) 0.155 
CDR 0.0 (0.0)bc 0.83 (0.38)a 0.63 (0.49)a <0.001 
MMSE 28.06 (1.56)c 25.56 (4.19) 23.27 (3.89)a <0.001 
STMB – unbound 83.69 (10.20)bc 71.72 (13.41)a 57.14 (17.43)a <0.001 
STMB – bound 74.31 (17.57)c 66.61 (17.97)c 43.51 (22.75) ab <0.001 
Binding cost 11.66 (7.56)c 7.44 (9.40)c 26.23 (13.96)ab 0.002 
  
The results of the binding cost analyses indicated that the AD group showed a significantly higher 
percentage drop (26.23%) than the other groups (controls = 11.66% and bvFTD = 7.44%). There was a 
significant difference between controls and AD (p = 0.011) and bvFTD and AD (p = 0.009), but no 
difference between controls and bvFTD (p = 1.000) in the Kruskal-Wallis test. 
 
ROC analyses using the bound STMB (Table 2) indicated that the highest diagnostic accuracy was obtained 
when the test contrasted the controls and the AD groups. Moderate accuracy was observed when the two 
dementia groups were contrasted. Low accuracy was observed when the STMB was used to differentiate 
controls from bvFTD. ROC analyses using the cost of binding variable indicated that the highest diagnostic 
accuracy was observed when the test contrasted AD and bvFTD groups, followed closely by the contrast 
of controls and AD, and it showed low accuracy when contrasting controls and bvFTD. 
 
 
 
 
Table 2. Diagnostic accuracy for the bound condition and for binding cost in the STMB 
 Groups Cut off AUC  Sensitivity Specificity 
Bound condition 
Controls x AD 58.50% 0.853 0.844 0.800 
Controls x bvFTD 64% 0.631 0.781 0.500 
AD x bvFTD 58.50% 0.794 0.722 0.800 
Binding cost 
Controls x AD 57.50% 0.722 0.750 0.645 
Controls x bvFTD 53.50% 0.559 0.548 0.556 
AD x bvFTD 57.50% 0.739 0.750 0.722 
Note. AD = Alzheimer’s disease; bvFTD = behavioral variant Frontotemporal Dementia. AUC = area under 
the curve. STMB = Short-term memory binding. Binding Cost = percentage of the performance drop 
between the unbound to the bound conditions of the free recall STMB. 
 
The STMB test (bound condition) showed no significant correlation with Age (p = 0.541) or Education (p 
= 0.098), and showed a significant correlation coefficient of 0.454 (p < 0.001) with the MMSE, indicating 
it maintains a moderate association with general cognition. 
 
Discussion 
 
In this study, we aimed to compare cognitively healthy controls, patients with AD and bvFTD on the free 
recall modality of the STMB test. For the unbound condition, there was a significant difference between 
controls and both dementia groups (controls > bvFTD = AD). However, in the bound condition, AD patients 
showed significantly lower performance compared to bvFTD and controls, and there was no difference 
between controls and bvFTD (controls = bvFTD > AD). ROC analyses confirmed that the bound condition 
of the STMB test can be helpful in the differential diagnosis between AD and bvFTD. When we compared 
the groups in the binding cost (relative percentage drop in performance from the unbound to the bound 
condition), the results showed that the AD group presented the highest percentage drop when compared 
with the other groups. In ROC analyses, the binding cost yielded lower accuracy to distinguish the clinical 
groups when compared with the bound condition. Therefore, present results suggest that the condition of 
the SMB test with best diagnostic accuracy is that assessing free recall of bound features.  
 To discuss our results, we would like to consider these in the light of previous findings [13,15]. Such earlier 
evidence may provide valuable insights to best interpret our current data. In Table 3 below the results from 
the current study were contrasted with those previously reported. These earlier studies used an easier 
version of the task, whereby AD patients were presented with screens of 4 features, whereas in the present 
study their screens presented 6 features. Also, controls were exposed to a larger number features on the 
screen, in an attempt to equate task difficulty among groups. Of note, controls and AD patients in the earlier 
studies were similar in age to participants of the present study but they had fewer years of education. Despite 
methodological differences, present results are largely consistent with previous findings. 
 
Table 3. Comparison between present results and previous studies. 
 STMB 
Present 
study 
Della Sala and 
colleagues 
Parra and colleagues 
(Experiment 1) 
Controls 
Unbound 83.69% 68% 83% 
Bound 74.31% 63% 75% 
Age / 
Education 
67.84 / 
12.25 
69.35 / 7.25 
69.78 / 7.08 
Features 6 8 6 
AD 
Unbound 57,14% 58% 63% 
Bound 43,51% 25% 40% 
Age / 
Education 
71.40 / 
10.09 
72.93 / 7.13 
73.26 / 6.39 
Features 6 4 4 
Note. AD = Alzheimer’s disease; STMB = Short-term memory binding test. Parra and colleagues[15] did 
not include a FTD group and in Della Sala and colleagues[13] the FTD group included language variants. 
Therefore, comparisons with the present FTD group are limited. 
 
 
Compared to Parra and colleagues[15], our results were similar for both clinical groups, even with 
differences in education and with patients performing a task with more items. Compared to Della Sala and 
colleagues[13], the present study showed a smaller performance drop in AD patients from the unbound to 
the bound condition. This may be due to the higher difficulty of the present task and to the fact that Della 
Sala and colleagues[13] included patients in the moderate stage of AD dementia, while the present sample 
included only mild cases (CDR 0.5 or 1.0). Regarding FTD patients, Della Sala and colleagues[13] reported 
a performance of approximately 65% in the unbound condition and 80% in the bound condition, and, in 
present study, this clinical group performed approximately at 71% and 67%, respectively. That difference 
might be explained by the fact that Della Sala and colleagues[13] included the semantic variant of FTD in 
their group, whereas the current study included solely bvFTD. The semantic variant and bvFTD show 
different patterns of brain atrophy. While bvFTD patients show atrophy especially in areas of the frontal 
lobe, anterior cingulate and anterior insula [21,22], semantic variant patients have anterior and inferior 
temporal lobe atrophy (in particular, the temporal pole) and perirhinal cortices [23–25]. 
  
In Della Sala and colleagues[13] and Parra and colleagues[15], a smaller set size was used for dementia 
patients to equate task difficulty across patients and healthy controls. It may be argued that in clinical 
settings this titration strategy is challenging to implement, as it is impossible to know a priori if someone 
is a patient or a control. To overcome this barrier, in the present study the same set size was used for controls 
and patients, with 6 features per screen to avoid ceiling effects among controls. Increased task difficulty for 
patients with dementia may have led to an underestimation of the binding cost, as performance in the 
unbound condition may have shown a further drop due to the task difficulty, as shown in the comparison 
between the present study and Parra and colleagues[15]. Therefore, arrays of 4 features might be a more 
suitable set size if the classical dissociation (performance on unbound > performance on bound) is sought 
for diagnostic accuracy. The fact that increased task difficulty reduced binding drop (as performance in the 
unbound condition was already low) may have generated lower scores for the binding cost variable, as 
observed in Results. 
 
The present findings are also in line with studies that used the change detection paradigm to assess STMB 
[9,11]. Taken together, the results from these various studies indicate that short-term conjunctive memory 
is impaired specifically in AD, even in mild dementia stages, regardless of the nature of the stimuli used 
(meaningless shapes with non-nameable colors or common objects with common colors) or the retrieval 
function required (recognition or recall). These results have important clinical implications, as the test could 
be useful to differentiate AD from bvFTD in the early stages of the disease, which has proven to be quite 
challenging [3,4,26].  
 
We acknowledge that recent studies have pursued similar aims using different memory binding paradigms. 
One particular type of memory binding, known as relational binding [8], refers to the recall of the 
association between two different items, for instance, when one recalls a name associated with a face, or 
information associated with a context, or even the semantic meaning of two words. In the present study, we 
have used a conjunctive memory binding paradigm, as the recalled feature conjunctions create unique 
representations (i.e., integrated objects) in memory. Relational and conjunctive memory binding are 
affected by AD. For instance, the Free and Cued Selective Reminding (FCSR) test [27] showed to be an 
accurate predictor of AD [28] and mild cognitive impairment (MCI) [29] and possibly fares better in AD 
and MCI diagnosis than traditional memory tests, such as the Rey Auditory Verbal Learning test [30]. 
However, relational binding is affected by age [31] (but see [32]). Conjunctive binding, on the other hand, 
is not affected by age or education, as the correlation evidence in the present study also suggests, and 
showed higher diagnostic accuracy for AD when compared with the FCSR test [33]. This may be explained 
by the fact that relational binding is related to hippocampus activity [34–36], whereas conjunctive binding 
does not seem to be [37,38]. In addition, hippocampal degeneration does not seem to be an ideal marker to 
differentiate AD from bvFTD [39] neither it seems to be the earliest pathological change causing memory 
deficits in AD[40]. 
 
A few limitations of the study should be noted. Although greater than samples recruited for previous STBM 
studies, the samples in the current study were not large, restricting the generalization of the outcome. 
Moreover, we did not have biomarker evidence for the control group making it possible to have included 
in this group people with normal cognition but in a preclinical stage of the disease. This could have 
decreased the observed discrepancies between controls and the pathological groups. 
 
In conclusion, our results indicate that the free recall version of the STMB test can be used for clinical 
purposes and may aid the early diagnosis of AD, differentiating this condition from other dementias and 
validating previous studies with this paradigm. Future studies should continue to explore the specificity of 
STMB deficits in AD versus other dementias and consider both conjunctive and relational paradigms 
[32,41] of temporary binding. Future studies should also address the correlations between performance in 
STMB tests and biomarkers such as structural, functional or molecular neuroimaging, as well as CSF 
measures. 
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